Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Bryce Lim
Decoding the regulatory programs governing glioblastoma plasticity
Abstract Glioblastoma is incurable and resistant to therapy despite genomic stability under treatment1,2,3,4,5,6,7,8, suggesting that non-genetic cellular plasticity is a central driver of progression. Whether such plasticity reflects stochastic state switching or is governed by predictable gene regulation has remained unclear9,10,11,12,13.
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy
|
Abstract Small cell lung cancer (SCLC) patients frequently experience a remarkable response to first-line therapy. Follow up maintenance treatments aim to control residual tumor cells, but generally fail due to cross-resistance, inefficient targeting of tumor vulnerabilities, or dose-limiting toxicity, resulting in relapse and disease progression.
By Jana Samarin, Piotr Fabrowski, Mona Malz, Daniel Pastor-Flores, Daniel Kazdal, Roman Kurilov, Nicole de Vries, Lisa Renz, Kamini Kaushal, Michael Morgen, Tobias P. Dick, Gerhard Hamilton, Martina U Muckenthaler, Moritz Mall, Bryce Lim, Glynis Klinke, Martin L. Sos, Julia Frede, Aubry K. Miller, Hamed Alborzinia, Eberhard Amtmann, Minerva J. Taeubert, Hannelore Pink, Franziska Deis, Johanna Hummel-Eisenbeiss, Taishi Kanamaru, Nikolas Gunkel
|
Nature
Verified
Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis - Nature Genetics
Abstract Cell fate plasticity enables development, yet unlocked plasticity is a cancer hallmark. While transcription master regulators induce lineage-specific genes to restrict plasticity, it remains unclear whether plasticity is actively suppressed by lineage-specific repressors. Here we computationally predict so-called safeguard repressors for 18 cell types that block phenotypic plasticity lifelong.
Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumourigenesis
Abstract Cell fate plasticity enables development, yet unlocked plasticity is a cancer hallmark. Regulating cell identity requires gene activation and repression. While master regulators induce lineage-specific genes to restrict plasticity, it remains unclear whether unwanted plasticity is actively suppressed by lineage-specific repressors. Here, we computationally predict so-called safeguard repressors for 18 cell types that block phenotypic plasticity lifelong.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Bryce
Contact Bryce, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack